Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
EBRUMA
Third Extension - Granted
Show more
Pharmaceutical preparations for the treatment of hematological, gastrointestinal, neuromuscular, muscular, cardiovascular, metabolic, immunological, inflammatory, oncological, ophthalmological, neurological, musculoskeletal, bone, connective tissue, dermatological, infectious, autoimmune, nephrological, hepatological, allergic, genetic, respiratory, viral diseases and disorders, and for the treatment of pain
Class 5 – Pharmaceuticals & supplements
Status timeline
- 9 Nov 2023Application filedNew Application Entered
- 6 Jun 2024Assigned to an examining attorneyAssigned To Examiner
- 6 Jun 2024Approved for publicationApproved For Pub - Principal Register
- 9 Jul 2024Published for oppositionPublished For Opposition
- 3 Sep 2024Notice of allowance issued — statement of use requiredNoa Mailed - Sou Required From Applicant
- 27 Feb 2025Statement-of-use extension 1 grantedSou Extension 1 Granted
- 30 Aug 2025Statement-of-use extension 2 grantedSou Extension 2 Granted
- 2 Mar 2026Statement-of-use extension 3 grantedSou Extension 3 Granted
All 23 events
| 2026-03-03 | Notice Of Approval Of Extension Request E-Mailed |
| 2026-03-02 | Sou Teas Extension Received |
| 2026-03-02 | Sou Extension 3 Filed |
| 2026-03-02 | Sou Extension 3 Granted |
| 2025-09-15 | Notice Of Approval Of Extension Request E-Mailed |
| 2025-08-30 | Sou Teas Extension Received |
| 2025-08-30 | Sou Extension 2 Filed |
| 2025-08-30 | Sou Extension 2 Granted |
| 2025-06-30 | Teas Change Of Owner Address Received |
| 2025-06-30 | Applicant/Correspondence Changes (Non-Responsive) Entered |
| 2025-06-30 | Teas Change Of Correspondence Received |
| 2025-02-27 | Sou Extension 1 Granted |
| 2025-02-27 | Notice Of Approval Of Extension Request E-Mailed |
| 2025-02-26 | Sou Teas Extension Received |
| 2025-02-26 | Sou Extension 1 Filed |
| 2024-09-03 | Noa Mailed - Sou Required From Applicant |
| 2024-07-09 | Published For Opposition |
| 2024-07-09 | Official Gazette Publication Confirmation E-Mailed |
| 2024-06-19 | Notification Of Notice Of Publication E-Mailed |
| 2024-06-06 | Assigned To Examiner |
| 2024-06-06 | Approved For Pub - Principal Register |
| 2024-01-28 | New Application Office Supplied Data Entered |
| 2023-11-09 | New Application Entered |
Goods & services by class
Class 5 Pharmaceuticals & supplements
Pharmaceutical preparations for the treatment of hematological, gastrointestinal, neuromuscular, muscular, cardiovascular, metabolic, immunological, inflammatory, oncological, ophthalmological, neurological, musculoskeletal, bone, connective tissue, dermatological, infectious, autoimmune, nephrological, hepatological, allergic, genetic, respiratory, viral diseases and disorders, and for the treatment of pain
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 4 Mar 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.